SENATE 1388117th CongressCommittee on the Judiciary. Ordered to be reported without amendment favorably.
Prescription Pricing for the People Act of 2021
- Last Action
- 7/29/2021
Actions
- 2021-07-29Committee on the Judiciary. Ordered to be reported without amendment favorably.
- 2021-04-27Read twice and referred to the Committee on the Judiciary.
- 2021-04-27Introduced in Senate
CRS Summary
As of 2021-04-27 (00)
Prescription Pricing for the People Act of 2021
This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
Cosponsors (10)
- Maria Cantwell (D-WA)
- Marsha Blackburn (R-TN)
- Richard Blumenthal (D-CT)
- Joni Ernst (R-IA)
- Thomas Tillis (R-NC)
- Tommy Tuberville (R-AL)
- John Boozman (R-AR)
- Mike Braun (R-IN)
- Shelley Capito (R-WV)
- James Lankford (R-OK)
Subjects
- Business ethics
- Business records
- Civil actions and liability
- Competition and antitrust
- Congressional oversight
- Consumer affairs
- Health care costs and insurance
- Health information and medical records
- Inflation and prices
- Manufacturing
- Prescription drugs
- Retail and wholesale trades
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.